[{"address1": "6000 Shoreline Court", "address2": "Suite 102", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "925 407 1049", "website": "https://www.nkartatx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a lymphocyte that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, that is in phase I for the treatment of various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.", "fullTimeEmployees": 167, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul J. Hastings", "age": 63, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 938414, "exercisedValue": 0, "unexercisedValue": 1016711}, {"maxAge": 1, "name": "Dr. Alicia J. Hager", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 590941, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa  Levin C.A., CPA", "age": 38, "title": "Chief Financial & Business Officer and Principal Accounting Officer", "yearBorn": 1985, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ralph  Brandenberger Ph.D.", "age": 54, "title": "Chief Technical Officer", "yearBorn": 1969, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Trager Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1963, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Mann", "title": "Vice President of Public Affairs and Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David R. Shook M.D.", "age": 45, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 14.63, "open": 14.5, "dayLow": 13.71, "dayHigh": 15.11, "regularMarketPreviousClose": 14.63, "regularMarketOpen": 14.5, "regularMarketDayLow": 13.71, "regularMarketDayHigh": 15.11, "beta": 0.739, "forwardPE": -5.62249, "volume": 616148, "regularMarketVolume": 616148, "averageVolume": 2146610, "averageVolume10days": 844160, "averageDailyVolume10Day": 844160, "bid": 14.03, "ask": 14.9, "bidSize": 800, "askSize": 800, "marketCap": 687012224, "fiftyTwoWeekLow": 1.28, "fiftyTwoWeekHigh": 16.24, "fiftyDayAverage": 9.9415, "twoHundredDayAverage": 4.399025, "currency": "USD", "enterpriseValue": 500864800, "floatShares": 17725911, "sharesOutstanding": 49072300, "sharesShort": 4241849, "sharesShortPriorMonth": 3838804, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0864, "heldPercentInsiders": 0.07373, "heldPercentInstitutions": 0.96351, "shortRatio": 5.36, "shortPercentOfFloat": 0.123100005, "bookValue": 6.049, "priceToBook": 2.3144321, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -122329000, "trailingEps": -2.5, "forwardEps": -2.49, "enterpriseToEbitda": -3.82, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "NKTX", "underlyingSymbol": "NKTX", "shortName": "Nkarta, Inc.", "longName": "Nkarta, Inc.", "firstTradeDateEpochUtc": 1594387800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f8b318d7-cd1e-386d-9dfd-185f3cf0df4b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 14.0, "targetHighPrice": 25.0, "targetLowPrice": 9.0, "targetMeanPrice": 15.63, "targetMedianPrice": 15.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 275612992, "totalCashPerShare": 5.616, "ebitda": -131101000, "totalDebt": 89465000, "quickRatio": 10.749, "currentRatio": 10.967, "debtToEquity": 30.142, "returnOnAssets": -0.18611999, "returnOnEquity": -0.35147998, "freeCashflow": -117035000, "operatingCashflow": -70137000, "financialCurrency": "USD", "trailingPegRatio": null}]